- ￥960
- EK-BIO（酶研生物）
- MH10515
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格：
48T
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验TSA Treatment of Mammalian Cells
) towards the nuclear periphery. HP1 domain disruption upon TSA treatment is monitored by immunofluorescence using an antibody against HP1alpha (2HP1H5) from EUROMEDEX. Reversibility of the drug effect was obtained within 20 hours after TSA removal. (Figure
TSA Treatment of Mammalian Cells (PROT09)
heterochromatin domains) towards the nuclear periphery. HP1 domain disruption upon TSA treatment is monitored by immunofluorescence using an antibody against HP1alpha (2HP1H5) from EUROMEDEX. Reversibility of the drug effect was obtained within 20 hours
detection involves enhancement of fluorescent signals by tyramide signal amplification (TSA) and effective inactivation of the antibody–POD conjugate prior to the following detection round. We provide a detailed description of embryo preparation
技术资料暂无技术资料 索取技术资料
